09 July 2020

Sinocelltech launches IPO on STAR Market

On 22 June, Sinocelltech Group Limited (" Sinocelltech") made its initial public offering (“IPO”) on the SSE STAR Market (stock code: 688520). Sinocelltech applied the fifth set of listing standards on the Sci-Tech Innovation Board. The issuance raised a total of RMB 1.282 billion by issuing 50 million new shares at the price of RMB 25.64 each.

Sinocelltech is an innovative biopharmaceutical R&D and industrial development company dedicated to the development of biomedicines with differentiated competitive advantages. It focuses on multiple therapeutic and preventive fields such as malignant tumors, autoimmune diseases, infectious diseases and genetic diseases.

As the issuer’s counsel, King & Wood Mallesons (KWM) provided legal services in relation to the demonstration of listing path scheme, employee equity incentive, etc. throughout the listing process to successfully land on the Sci-Tech innovation board.

The KWM team included partners Gao Yimin and Jia Diyan, with support from senior associate Liu Zhihui. Jiang Yifeng is the lead partner.


Media contact

Share on LinkedIn Share on Facebook Share on Twitter
    You might also be interested in

    In July 2021, King & Wood Mallesons (KWM) Dispute Resolution partner Han Yang was recognised as one of the 2021 ALB China Top 15 Rising Lawyers by Asian Legal Business (ALB) for her outstanding...

    20 July 2021

    On 15 July 2021, Medlive Technology Co., Ltd. (Medlive Technology) made its IPO on the Main Board of the Hong Kong Stock Exchange.

    19 July 2021

    Asia’s leading international firm, King & Wood Mallesons (KWM), has confirmed the promotion of 32 lawyers in China and ten lawyers in Australia to partner.

    07 July 2021

    King & Wood Mallesons (KWM) took out the top award in this year’s Financial Times (FT) Asia-Pacific Innovative Lawyers program.

    14 May 2021

    This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

    For more information on which cookies we use then please refer to our Cookie Policy.